Clinical characteristics and risk factors of osteoporosis among older Asian men with type-2 diabetes mellitus, hypertension, or hyperlipidaemia
Yu Quan Tan,
No information about this author
Ding Xuan Ng,
No information about this author
Kalaipriya Gunasekaran
No information about this author
et al.
Archives of Osteoporosis,
Journal Year:
2024,
Volume and Issue:
19(1)
Published: Sept. 5, 2024
Language: Английский
A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases
Research in Social and Administrative Pharmacy,
Journal Year:
2024,
Volume and Issue:
20(9), P. 905 - 910
Published: May 23, 2024
The
variety
of
methods
for
counting
medications
may
lead
to
confusion
when
attempting
compare
the
extent
polypharmacy
across
different
populations.
Language: Английский
Association Between the Use of Orexin Receptor Antagonists and Falls or Fractures: A Meta-Analysis
Guobiao Pan,
No information about this author
Lingzhi Ni,
No information about this author
Haohao Yan
No information about this author
et al.
Journal of Psychiatric Research,
Journal Year:
2024,
Volume and Issue:
176, P. 393 - 402
Published: June 25, 2024
Language: Английский
Association between Polypharmacy and Adverse Events in Patients with Alzheimer’s Disease: An Analysis of the Japanese Adverse Drug Event Report Database (JADER)
Nobuhiro Otani,
No information about this author
Kanae Kanda,
No information about this author
Nlandu Roger Ngatu
No information about this author
et al.
Medicina,
Journal Year:
2024,
Volume and Issue:
60(10), P. 1633 - 1633
Published: Oct. 6, 2024
:
Alzheimer's
disease
is
a
global
health
concern,
with
rising
prevalence
among
the
elderly.
Current
pharmacological
treatments,
including
acetylcholinesterase
inhibitors
(AChEIs)
and
N-Methyl
D-Aspartate
(NMDA)
receptor
antagonists,
are
associated
adverse
events
(AEs),
particularly
in
context
of
polypharmacy.
This
study
aimed
to
investigate
relationship
between
treatment
combinations,
number
concomitant
medications,
occurrence
AEs.
Language: Английский
The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol
Julie A. Womack,
No information about this author
Micaela M. Leblanc,
No information about this author
Annette S. Sager
No information about this author
et al.
AIDS and Behavior,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 28, 2024
Language: Английский